Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function

Transplant Proc. 2002 Aug;34(5):1922-4. doi: 10.1016/s0041-1345(02)03124-x.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • C-Peptide / blood
  • Cytomegalovirus / isolation & purification
  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections / epidemiology*
  • Diabetes Mellitus, Type 1 / surgery*
  • Drug Therapy, Combination
  • Female
  • Graft Survival / physiology*
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Incidence
  • Islets of Langerhans Transplantation / immunology
  • Islets of Langerhans Transplantation / physiology*
  • Kidney Transplantation / immunology
  • Male
  • Postoperative Complications / virology*
  • Transplantation, Homologous
  • Virus Replication

Substances

  • C-Peptide
  • Immunosuppressive Agents